PL3324986T3 - Materiały i sposoby poprawy odpowiedzi odpornościowych oraz funkcji barierowej skóry lub błony śluzowej - Google Patents

Materiały i sposoby poprawy odpowiedzi odpornościowych oraz funkcji barierowej skóry lub błony śluzowej

Info

Publication number
PL3324986T3
PL3324986T3 PL16828408T PL16828408T PL3324986T3 PL 3324986 T3 PL3324986 T3 PL 3324986T3 PL 16828408 T PL16828408 T PL 16828408T PL 16828408 T PL16828408 T PL 16828408T PL 3324986 T3 PL3324986 T3 PL 3324986T3
Authority
PL
Poland
Prior art keywords
skin
materials
methods
immune responses
barrier function
Prior art date
Application number
PL16828408T
Other languages
English (en)
Polish (pl)
Inventor
Eva A. Berkes
Nicholas T. Monsul
Frederick T. BOEHM
Original Assignee
Quorum Innovations, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quorum Innovations, Llc filed Critical Quorum Innovations, Llc
Publication of PL3324986T3 publication Critical patent/PL3324986T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/143—Fermentum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
PL16828408T 2015-07-20 2016-07-19 Materiały i sposoby poprawy odpowiedzi odpornościowych oraz funkcji barierowej skóry lub błony śluzowej PL3324986T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562194630P 2015-07-20 2015-07-20
PCT/US2016/042939 WO2017015275A1 (en) 2015-07-20 2016-07-19 Materials and methods for improving immune responses and the skin and/or mucosal barrier function
EP16828408.1A EP3324986B1 (en) 2015-07-20 2016-07-19 Materials and methods for improving immune responses and the skin and/or mucosal barrier function

Publications (1)

Publication Number Publication Date
PL3324986T3 true PL3324986T3 (pl) 2022-04-04

Family

ID=57835147

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16828408T PL3324986T3 (pl) 2015-07-20 2016-07-19 Materiały i sposoby poprawy odpowiedzi odpornościowych oraz funkcji barierowej skóry lub błony śluzowej

Country Status (17)

Country Link
US (6) US9706778B2 (enExample)
EP (1) EP3324986B1 (enExample)
JP (1) JP6727285B2 (enExample)
KR (1) KR102258415B1 (enExample)
CN (1) CN108135947B (enExample)
AU (1) AU2016297539B9 (enExample)
BR (1) BR112018001187B1 (enExample)
CA (1) CA2991990C (enExample)
DK (1) DK3324986T3 (enExample)
ES (1) ES2904555T3 (enExample)
HU (1) HUE057494T2 (enExample)
IL (1) IL256973B (enExample)
MX (1) MX395076B (enExample)
PL (1) PL3324986T3 (enExample)
PT (1) PT3324986T (enExample)
WO (1) WO2017015275A1 (enExample)
ZA (1) ZA201800209B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0811530B1 (pt) 2007-05-14 2019-01-02 Research Foundation Of State Univ Of New York composição compreendendo indutor(es) de resposta fisiológica à dispersão ácido decanóico, superfície, solução, método ex vivo de tratamento ou inibição da formação de um biofilme sobre uma superfície
WO2017015275A1 (en) * 2015-07-20 2017-01-26 Quorum Innovations, Llc Materials and methods for improving immune responses and the skin and/or mucosal barrier function
EP3579930B1 (en) 2017-02-10 2026-05-20 De Maio Domingos, Mauricio METHOD FOR PROVIDING AN INJECTION TREATMENT PLAN FOR A SUBJECT WITH A TIRED APPEARANCE
US11253454B2 (en) * 2017-03-10 2022-02-22 Johnson & Johnson Consumer Inc. Method for affecting touch
GB201807576D0 (en) 2018-05-09 2018-06-20 Skinbiotherapeutics Plc Compositions and uses thereof
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
EP3685669A1 (en) * 2019-01-23 2020-07-29 Chrisal NV Composition for the decontamination and inoculation of surfaces
EP3741398A1 (en) * 2019-05-20 2020-11-25 Medizinische Hochschule Hannover Method for coating a medical device and coated medical device
IL293368B2 (en) * 2019-11-26 2026-05-01 Quorum Innovations Llc New barrier and protective preparations and their use
US12195502B2 (en) 2020-05-06 2025-01-14 Quorum Innovations, Llc Protein, and therapeutic and cosmetic uses thereof
KR102167387B1 (ko) * 2020-05-14 2020-10-19 코스맥스 주식회사 피부 장벽 강화, 피부 보습 또는 항노화를 위한 조성물
CN116133669A (zh) 2020-06-06 2023-05-16 群体创新有限责任公司 用于抑制包括冠状病毒感染的病毒感染的材料和方法
MX2023003595A (es) * 2020-09-29 2023-04-05 Unilever Ip Holdings B V Una composicion para el cuidado personal que comprende aminoacidos.
US20220142560A1 (en) * 2020-11-06 2022-05-12 Johnson & Johnson Consumer Inc. Microbiome and metobolome clusters to evaluate skin health
KR102573754B1 (ko) * 2021-02-25 2023-09-01 주식회사 차메디텍 신규의 펩타이드 및 이를 포함하는 피부장벽 강화 또는 피부가려움증 억제를 위한 화장료 조성물
KR102389749B1 (ko) * 2021-05-14 2022-04-22 주식회사 세바바이오텍 피부장벽강화 및 항주름 활성을 갖는 피부 유래 락토바실러스 퍼멘텀 아종 세바­１０１ 균주 및 이의 용도
CN113832050B (zh) * 2021-08-13 2022-10-21 广东省科学院微生物研究所(广东省微生物分析检测中心) 一株高效合成烟酰胺、抗光老化的发酵乳杆菌xjc60及其应用
CN114717162A (zh) * 2022-05-17 2022-07-08 廖梅香 发酵乳杆菌及其应用
CN118126875B (zh) * 2024-02-05 2024-11-05 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） 一株表皮葡萄球菌及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPS057102A0 (en) * 2002-02-15 2002-03-07 Vri Biomedical Ltd Compositions and methods for treatment of skin disorders
WO2005009342A2 (en) * 2003-07-16 2005-02-03 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
EP1736537A1 (en) * 2005-06-22 2006-12-27 OrganoBalance GmbH Methods and means for protecting the skin against pathogenic microorganisms
JP2007284360A (ja) 2006-04-13 2007-11-01 Mitsukan Group Honsha:Kk 乳酸菌由来のｐｐａｒ依存的遺伝子転写活性化組成物
WO2008064893A1 (en) * 2006-12-01 2008-06-05 Organobalance Gmbh Compositions, kits and uses for protecting the skin against pathogenic microorganisms
EP2227239A2 (en) * 2007-12-06 2010-09-15 Arla Foods Amba Probiotic bacteria and regulation of fat storage
CZ302297B6 (cs) * 2009-11-04 2011-02-09 Bio Agens Research And Development - Bard, S.R.O. Protiplísnová smes s houbovým organismem Pythium oligandrum
JP2013527155A (ja) * 2010-04-16 2013-06-27 ダボス ライフ サイエンス ピーティーイー． リミテッド 皮膚科用途のための少なくとも１つのビタミンｅ成分およびチロシナーゼ阻害剤の相乗的相互作用
WO2012107244A1 (en) * 2011-02-09 2012-08-16 Organobalance Gmbh Peptide for use in the treatment of skin conditions
CN111518866A (zh) 2011-03-01 2020-08-11 群体创新有限责任公司 用于治疗与致病生物膜相关之病症的材料和方法
CN102226157B (zh) * 2011-05-06 2013-01-09 北京龙科方舟生物工程技术有限公司 一株发酵乳杆菌及其应用
CN104010648A (zh) 2011-12-07 2014-08-27 可尔必思株式会社 包含乳酸菌或其处理物的脂质代谢和/或糖代谢改善剂
WO2017015275A1 (en) * 2015-07-20 2017-01-26 Quorum Innovations, Llc Materials and methods for improving immune responses and the skin and/or mucosal barrier function

Also Published As

Publication number Publication date
US20260034184A1 (en) 2026-02-05
HUE057494T2 (hu) 2022-05-28
AU2016297539A1 (en) 2018-02-08
US10004772B2 (en) 2018-06-26
EP3324986B1 (en) 2021-11-24
US20170020139A1 (en) 2017-01-26
JP6727285B2 (ja) 2020-07-22
US11564957B2 (en) 2023-01-31
ZA201800209B (en) 2018-12-19
IL256973A (en) 2018-03-29
BR112018001187B1 (pt) 2022-02-15
US12440521B2 (en) 2025-10-14
US20230165915A1 (en) 2023-06-01
IL256973B (en) 2020-06-30
CA2991990A1 (en) 2017-01-26
JP2018527322A (ja) 2018-09-20
AU2016297539B9 (en) 2019-11-28
PT3324986T (pt) 2022-01-26
MX395076B (es) 2025-03-24
US20170296599A1 (en) 2017-10-19
AU2016297539B2 (en) 2019-10-31
KR20180023012A (ko) 2018-03-06
ES2904555T3 (es) 2022-04-05
WO2017015275A1 (en) 2017-01-26
DK3324986T3 (da) 2022-01-31
US20170224748A1 (en) 2017-08-10
CN108135947B (zh) 2022-06-14
US9706778B2 (en) 2017-07-18
CA2991990C (en) 2024-04-16
EP3324986A1 (en) 2018-05-30
KR102258415B1 (ko) 2021-05-28
BR112018001187A2 (pt) 2018-09-11
HK1253067A1 (zh) 2019-06-06
CN108135947A (zh) 2018-06-08
EP3324986A4 (en) 2019-01-09
US10617726B2 (en) 2020-04-14
US20200215130A1 (en) 2020-07-09
MX2018000870A (es) 2018-05-15

Similar Documents

Publication Publication Date Title
IL256973B (en) Materials and methods for improving immune responses and skin and/or mucosal barrier activity
ZA201805805B (en) Formulations and methods
GB201508074D0 (en) People detection
IL254977B (en) Biological conjugates and their uses
EP3174552A4 (en) Flagellin-based agents and uses including effective vaccination
PT3458509T (pt) Produtos de alumina e uso dos mesmos em composições de polímero com alta condutividade térmica
EP3129402A4 (en) Site-specific antibody-drug glycoconjugates and methods
GB201411913D0 (en) Cosmetic methods and products
ZA201903977B (en) Pet food compositions and methods for the same
ZA202108599B (en) Anti-tnfalpha-antibodies and functional fragments thereof
SG11202000029PA (en) Anti-tnfalpha-antibodies and functional fragments thereof
GB201608779D0 (en) Methods and compounds
GB201521318D0 (en) Motorised karts
ZA201802483B (en) Mouthwash products and methods
GB201416293D0 (en) Methods and preparations
GB201710288D0 (en) Products and methods
EP3325712A4 (en) ADVANCED MICROFIBERS AND ASSOCIATED METHODS
IL261261A (en) Antibodies against tnf-alpha and functional fragments thereof
GB201608776D0 (en) Methods and compounds
GB201610647D0 (en) Improved sensor and associated methods
IL261098A (en) Antibodies against tnf-alpha and functional fragments thereof
GB201517786D0 (en) Methods and materials
IL261793A (en) Anti-tnfalpha antibodies and their functional parts
PL3438050T3 (pl) Biały materiał pochłaniający promieniowanie w bliskiej podczerwieni oraz sposób jego wytwarzania
ZA201903979B (en) Pet food compositions and methods for the same